This inventor holds 2 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2008-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2013
Title: Chee M Ng: Innovator in HER Antibody Dosing
Introduction
Chee M Ng is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of HER antibodies. With a total of 2 patents, his work has the potential to impact cancer treatment protocols.
Latest Patents
Ng's latest patents focus on the fixed dosing of HER antibodies, specifically Pertuzumab. This innovation aims to streamline the administration of these critical therapies, ensuring that patients receive optimal dosages for effective treatment.
Career Highlights
Chee M Ng is currently employed at Genentech, Inc., a leading biotechnology company known for its pioneering work in pharmaceuticals. His role at Genentech has allowed him to collaborate with some of the brightest minds in the industry.
Collaborations
Throughout his career, Ng has worked alongside esteemed colleagues such as David E Allison and Rene Bruno. These collaborations have fostered an environment of innovation and have contributed to the advancement of therapeutic solutions.
Conclusion
Chee M Ng's contributions to the field of HER antibody dosing exemplify the importance of innovation in biotechnology. His work not only enhances treatment efficacy but also showcases the collaborative spirit of the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile